Compugen Ltd (NASDAQ:CGEN)

6.74
Delayed Data
As of Jul 02
 -0.09 / -1.32%
Today’s Change
6.10
Today|||52-Week Range
10.02
-19.09%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$342.1M

Company Description

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Tel Aviv, Israel.

Contact Information

Compugen Ltd.
72 Pinchas Rosen Street
Tel Aviv Tel Aviv 69512
P:(723) 765-8585
Investor Relations:

Employees

Shareholders

Other institutional5.19%
Mutual fund holders5.07%
Individual stakeholders--

Top Executives

Anat Cohen-DayagPresident & Chief Executive Officer
Ari KrashinChief Financial Officer
Eyal NeriaVice President-Research & Development
Zurit LevineVice President-Research & Discovery
Tsipi Keren-LehrerVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account